Kotak MNC Fund Regular-Growth
Mid CapEquity: Thematic-MNCबहुत अधिक जोखिम
PaisaSmart रेटिंगअभी रेट नहीं किया गया
यह रेटिंग क्यों
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
हमारा स्कोर दीर्घकालिक प्रदर्शन, जोखिम और निरंतरता को तौलता है — केवल पिछले रिटर्न को नहीं।
रिटर्न
8 Oct 2026 तक
1W
-1.75%
1M
-5.06%
3M
-1.78%
6M
+12.96%
9M
+11.81%
1Y
+14.10%
लॉन्च से अब तक
+9.74%
पोर्टफोलियो
31 Aug 2026 तक
मार्केट-कैप विभाजन
लार्ज कैप35.76%मिड कैप29.63%स्मॉल कैप34.62%
P/E
43.02
P/B
7.08
स्टाइल
Growth
सेक्टर आवंटन
Capital Goods25.81%
Healthcare21.02%
Automobile17.58%
Consumer Staples14.22%
Financial6.85%
Metals & Mining4.73%
Technology3.80%
Services1.44%
होल्डिंग्स (45)
| होल्डिंग | फंड का % | मूल्य | शेयर |
|---|---|---|---|
| Maruti Suzuki India Ltd. | 4.99% | ₹115.15 Cr | 85,000 |
| MTAR Technologies Ltd. | 4.27% | ₹98.61 Cr | 1,40,000 |
| Hindustan Unilever Ltd. | 4.26% | ₹98.37 Cr | 5,00,000 |
| Acutaas Chemicals Ltd. | 4.11% | ₹94.82 Cr | 3,00,000 |
| Azad Engineering Ltd. | 4.09% | ₹94.44 Cr | 3,30,000 |
| Oracle Financial Services Software Ltd. | 3.80% | ₹87.78 Cr | 70,000 |
| Britannia Industries Ltd. | 3.75% | ₹86.63 Cr | 1,65,000 |
| Nestle India Ltd. | 3.56% | ₹82.31 Cr | 5,50,000 |
| GE Vernova T&D India Ltd | 3.47% | ₹80.01 Cr | 1,80,000 |
| Sun Pharmaceutical Industries Ltd. | 3.44% | ₹79.39 Cr | 4,00,000 |
फंड विवरण
संक्षेप में
Long term capital growth. Investment in portfolio of predominantly in equity and equity related securities of multi national companies (MNC).
निवेश उद्देश्य
The scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC).
एग्ज़िट लोड
0.5% for redemption within 90 Days
फंड प्रकार
Open-ended
न्यूनतम एकमुश्त
₹100
न्यूनतम निकासी
₹100
लॉक-इन
कोई नहीं
SIP
उपलब्ध
SWP
उपलब्ध
STP
उपलब्ध
खरीद कट-ऑफ
15:00